Amanote Research
Register
Sign In
Combined Epidermal Growth Factor Receptor Targeting With the Tyrosine Kinase Inhibitor Gefitinib (ZD1839) and the Monoclonal Antibody Cetuximab (IMC-C225): Superiority Over Single-Agent Receptor Targeting
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-04-0870
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
October 1, 2004
Authors
P. Matar
Publisher
American Association for Cancer Research (AACR)
Related search
Responses of Human Colorectal Tumor Cells to Treatment With the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody ICR62 Used Alone and in Combination With the EGFR Tyrosine Kinase Inhibitor Gefitinib
Cancer Research
Cancer Research
Oncology
Conversion of a Murine Monoclonal Antibody A13 Targeting Epidermal Growth Factor Receptor to a Human Monoclonal Antibody by Guided Selection
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
Acneiform Lesions Secondary to ZD1839, an Inhibitor of the Epidermal Growth Factor Receptor
Clinical and Experimental Dermatology
Dermatology
Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in Vivo Tumor Targeting and Imaging
Small
Materials Science
Nanoscience
Engineering
Biomaterials
Medicine
Biotechnology
Nanotechnology
Chemistry
ZD1839 (‘Iressa’), a Specific Oral Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor, Potentiates Radiotherapy in a Human Colorectal Cancer Xenograft Model
British Journal of Cancer
Cancer Research
Oncology
TAS6417, a Novel Epidermal Growth Factor Receptor Inhibitor Targeting Exon 20 Insertion Mutations
Molecular Cancer Therapeutics
Cancer Research
Oncology
Nucleotide Binding by the Epidermal Growth Factor Receptor Protein-Tyrosine Kinase
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Targeting the Human Epidermal Growth Factor Receptor 2 in Esophageal Cancer
Cancer Control
Medicine
Oncology
Hematology
Monoclonal Antibody Against Epidermal Growth Factor Receptor Is Internalized Without Stimulating Receptor Phosphorylation.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
